{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:05:21Z","timestamp":1790802321411,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Osteosarcoma is a rare bone cancer in adolescents and young adults with a dismal prognosis because of metastatic disease and chemoresistance. Despite multiple clinical trials, no improvement in outcome has occurred in decades. There is an urgent need to better understand resistant and metastatic disease and to generate\n                    <jats:italic>in vivo<\/jats:italic>\n                    models from relapsed tumors. We developed eight new patient-derived xenograft (PDX) subcutaneous and orthotopic\/paratibial models derived from patients with recurrent osteosarcoma and compared the genetic and transcriptomic landscapes of the disease progression at diagnosis and relapse with the matching PDX. Whole exome sequencing showed that driver and copy-number alterations are conserved from diagnosis to relapse, with the emergence of somatic alterations of genes mostly involved in DNA repair, cell cycle checkpoints, and chromosome organization. All PDX patients conserve most of the genetic alterations identified at relapse. At the transcriptomic level, tumor cells maintain their ossification, chondrocytic, and trans-differentiation programs during progression and implantation in PDX models, as identified at the radiological and histological levels. A more complex phenotype, like the interaction with immune cells and osteoclasts or cancer testis antigen expression, seemed conserved and was hardly identifiable by histology. Despite NSG mouse immunodeficiency, four of the PDX models partially reconstructed the vascular and immune-microenvironment observed in patients, among which the macrophagic TREM2\/TYROBP axis expression, recently linked to immunosuppression. Our multimodal analysis of osteosarcoma progression and PDX models is a valuable resource to understand resistance and metastatic spread mechanisms, as well as for the exploration of novel therapeutic strategies for advanced osteosarcoma.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2023.1166063","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:27:06Z","timestamp":1686529626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria Eugenia Marques","family":"da Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Droit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Khneisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gomez-Brouchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Adam-de-Beaumais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Nolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Signolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Torrejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9rang\u00e8re","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damarys","family":"Loew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ayrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Geoerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Vassal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Marchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30096-1","article-title":"Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Piperno-Neumann","year":"2016","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.0734","article-title":"Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon Alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: first results of the EURAMOS-1 good response randomized controlled trial","volume":"33","author":"Bielack","year":"2015","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.063","article-title":"Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the cooperative osteosarcoma study group (COSS)","volume":"23","author":"Kempf-Bielack","year":"2005","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejca.2017.01.005","article-title":"Phase-II trials in osteosarcoma recurrences: a systematic review of past experience","volume":"75","author":"Omer","year":"2017","journal-title":"Eur J Cancer."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048262","article-title":"Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma","volume":"7","author":"Kresse","year":"2012","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.5772\/67068","article-title":"Microenvironment signals and mechanisms in the regulation of osteosarcoma","volume-title":"Osteosarcoma - biology, behavior and mechanisms","author":"Zhang","year":"2017"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.5772\/67448","article-title":"Immune environment and osteosarcoma","volume-title":"Osteosarcoma - biology, behavior and mechanisms","author":"Heymann","year":"2017"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03117-1","article-title":"Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma","volume":"5","author":"Lietz","year":"2022","journal-title":"Commun Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23119-7","article-title":"Author correction: single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"12","author":"Zhou","year":"2021","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709210","article-title":"Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-4189","article-title":"Immune infiltrate and tumor microenvironment transcriptional programs stratify pediatric osteosarcoma into prognostic groups at diagnosis","volume":"82","author":"Marchais","year":"2022","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/2159-8290.CD-17-1152","article-title":"Genome-informed targeted therapy for osteosarcoma","volume":"9","author":"Sayles","year":"2019","journal-title":"Cancer Discovery"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.19","article-title":"Patient-derived xenografts as in vivo models for research in urological malignancies","volume":"14","author":"Inoue","year":"2017","journal-title":"Nat Rev Urol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature23647","article-title":"Orthotopic patient-derived xenografts of paediatric solid tumours","volume":"549","author":"Stewart","year":"2017","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12967-015-0497-x","article-title":"Establishment of a patient-derived orthotopic osteosarcoma mouse model","volume":"13","author":"Blattmann","year":"2015","journal-title":"J Transl Med"},{"key":"B16","first-page":"64","article-title":"Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics","volume":"3","author":"Guilhamon","year":"2011","journal-title":"Genome Med."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1136","article-title":"The European MAPPYACTS trial: precision medicine program in pediatric and adolescent patients with recurrent malignancies","volume":"12","author":"Berlanga","year":"2022","journal-title":"Cancer Discovery"},{"key":"B18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/cancers11070997","article-title":"In-vitro and in-vivo establishment and characterization of bioluminescent orthotopic chemotherapy-resistant human osteosarcoma models in NSG mice","volume":"11","author":"da Costa","year":"2019","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.10.022","article-title":"Discovery of new fusion transcripts in a cohort of pediatric solid cancers at relapse and relevance for personalized medicine","volume":"27","author":"Dupain","year":"2019","journal-title":"Mol Ther."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.111","article-title":"Osteogenic fate of hypertrophic chondrocytes","volume":"24","author":"Yang","year":"2014","journal-title":"Cell Res."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Shultz","year":"1995","journal-title":"JI"},{"key":"B22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/cells8080889","article-title":"Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models","volume":"8","author":"Okada","year":"2019","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11999.0000000000000291","article-title":"Intratibial injection causes direct pulmonary seeding of osteosarcoma cells and is not a spontaneous model of metastasis: a mouse osteosarcoma model","volume":"476","author":"Maloney","year":"2018","journal-title":"Clin Orthop Relat Res"},{"key":"B25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.celrep.2019.09.071","article-title":"Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design","volume":"29","author":"Rokita","year":"2019","journal-title":"Cell Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5991","article-title":"Phase I study evaluating WEE1 inhibitor AZD1775 as monotherapy and in combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors","volume":"34","author":"Leijen","year":"2016","journal-title":"J Clin Oncol"},{"key":"B27","first-page":"8940","article-title":"Nat","volume":"6","author":"Kovac","year":"2015","journal-title":"Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2906","article-title":"Histone methyltransferase SETDB1: a common denominator of tumorigenesis with therapeutic potential","volume":"81","author":"Strepkos","year":"2021","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/15592294.2016.1169351","article-title":"ATRX binds to atypical chromatin domains at the 3\u2032 exons of zinc finger genes to preserve H3K9me3 enrichment","volume":"11","author":"Valle-Garc\u00eda","year":"2016","journal-title":"Epigenetics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22595","article-title":"COPS3 amplification and clinical outcome in osteosarcoma","volume":"109","author":"Yan","year":"2007","journal-title":"Cancer"},{"key":"B31","unstructured":""},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25611","article-title":"The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts","volume":"128","author":"R\u00f6ssler","year":"2011","journal-title":"Int J Cancer."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1346","article-title":"Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice","volume":"7","author":"Marques da Costa","year":"2018","journal-title":"Cancer Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0381","article-title":"Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial","volume":"23","author":"Harttrampf","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200600784","article-title":"myProMS, a web server for management and validation of mass spectrometry-based proteomic data","volume":"7","author":"Poullet","year":"2007","journal-title":"Proteomics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ","volume":"13","author":"Cox","year":"2014","journal-title":"Mol Cell Proteomics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v070.i01","article-title":"missMDA: a package for handling missing values in multivariate data analysis","volume":"70","author":"Josse","year":"2016","journal-title":"J Stat Software"},{"key":"B38","doi-asserted-by":"publisher","first-page":"i172","DOI":"10.1093\/bioinformatics\/bts236","article-title":"Xenome\u2013a tool for classifying reads from xenograft samples","volume":"28","author":"Conway","year":"2012","journal-title":"Bioinformatics"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"B43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"gr.257246.119","DOI":"10.1101\/gr.257246.119","article-title":"Accurate and efficient detection of gene fusions from RNA sequencing data","volume":"31","author":"Uhrig","year":"2021","journal-title":"Genome Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts617","article-title":"Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript","volume":"28","author":"Benelli","year":"2012","journal-title":"Bioinformatics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1101\/166322","article-title":"Fusion detection and quantification by pseudoalignment","volume":"166322","author":"Melsted","year":"2017","journal-title":"bioRxiv"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-018-1421-5","article-title":"SQUID: transcriptomic structural variation detection from RNA-seq","volume":"19","author":"Ma","year":"2018","journal-title":"Genome Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1101\/120295","article-title":"STAR-fusion: fast and accurate fusion transcript detection from RNA-seq","volume":"120295","author":"Haas","year":"2017","journal-title":"bioRxiv"},{"key":"B49","article-title":"Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector","volume":"454639","author":"Haas","year":"2022","journal-title":"bioRxiv"},{"key":"B50","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","article-title":"RCircos: an r package for circos 2D track plots","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Bioinf"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1166063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:27:15Z","timestamp":1686529635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1166063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":50,"alternative-id":["10.3389\/fonc.2023.1166063"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1166063","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"article-number":"1166063"}}